摘要
目的:探讨玻璃体腔注射康柏西普治疗病理性近视脉络膜新生血管的临床效果。方法:收治病理性近视脉络膜新生血管患者60例,采用玻璃体腔注射康柏西普治疗,观察治疗效果。结果:治疗后,BCVA和CMT显著优于治疗前(P<0.05)。结论:玻璃体腔注射康柏西普治疗病理性近视脉络膜新生血管的临床效果显著。
Objective:To explore the clinical effect of intravitreal injection of conbercept in the treatment of choroidal neovascularization in pathologic myopia.Methods:60 patients with choroidal neovascularization in pathologic myopia were selected,and they were treated with intravitreal injection of conbercept.We observed the treatment effect.Results:After treatment,BCVA and CMT were significantly better than those before treatment(P<0.05).Conclusion:The clinical effect of intravitreal injection of conbercept in the treatment of choroidal neovascularization in pathologic myopia was significant.
出处
《中国社区医师》
2018年第1期40-41,共2页
Chinese Community Doctors
关键词
玻璃体腔
康柏西普
病理性近视
脉络膜新生血管
Vitreous cavity
Conbercept
Pathologic myopia
Choroidal neovascularization
